NEW YORK (GenomeWeb) – BioMérieux today reported organic sales growth of 4 percent for the fourth quarter, with full year 2015 organic sales up 7 percent.

The Marcy L'Etoile, France-based in vitro diagnostics firm said Q4 organic sales growth was slower than previous quarters due to unfavorable prior-year comparatives and a delayed start to the flu season. Sales for the three months ending Dec. 31, 2015 were €553.1 million ($599.6 million), a like-for-like change of 4 percent from €505.7 million in the year-ago period.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Sponsored by

This webinar will provide a first-hand look at how a leading pathology lab implemented a next-generation sequencing panel to capture comprehensive molecular tumor profiles.

Sponsored by

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.